SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the December 2022 quarter is pegged at Rs. 765.63 millions, about 10.97% up against Rs. 689.92 millions recorded during the year-ago period.Profit saw a slight increase of 20.89%to Rs. 14.70  millions from Rs. 12.16 millions.The Operating Profit of the company witnessed a decrease to 70.76 millions from 72.12 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 765.63 689.92 10.97 2211.27 2066.06 7.03 2803.65 2493.09 12.46
Other Income 7.72 11.09 -30.39 17.16 25.47 -32.63 64.90 26.92 141.08
PBIDT 70.76 72.12 -1.89 194.77 221.52 -12.08 296.92 290.11 2.35
Interest 31.18 23.57 32.29 83.18 79.04 5.24 103.99 119.58 -13.04
PBDT 39.58 48.55 -18.48 111.59 142.48 -21.68 192.93 170.53 13.14
Depreciation 20.26 17.13 18.27 58.18 51.22 13.59 72.37 72.57 -0.28
PBT 19.32 31.42 -38.51 53.41 91.26 -41.47 120.56 97.96 23.07
TAX 4.62 19.26 -76.01 13.34 27.07 -50.72 34.77 6.99 397.42
Deferred Tax -3.10 0.47 -759.57 -14.12 -2.01 602.49 -19.38 3.21 -703.74
PAT 14.70 12.16 20.89 40.07 64.19 -37.58 85.79 90.97 -5.69
Equity 156.90 148.22 5.86 156.90 148.22 5.86 148.22 148.22 0.00
PBIDTM(%) 9.24 10.45 -11.59 8.81 10.72 -17.85 10.59 11.64 -8.99

Bal Pharma Share Price

78.45 1.75 (2.28%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×